In the present study we found that inhibition of the mTORC2 component RICTOR impairs activation of signaling pathways (AKT, SGK1), reduces expression of hypoxia-induced HIF-1α and diminishes secretion of critical cancer-promoting factors involved in stromal recruitment such as VEGF-A and IL-8. Here, VEGFA is linked to cancer.